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Prostaglandin E1-containing solutions in-
jected under the skin overlying the calvarium
of adult rats produced a visible resorptive
lesion within the bone in seven days. The
resorptive process was characterized by fi-
brous replacement of bone matrix and by in-
creased vascularity. Inflammatory cells were
not apparent.
Prostaglandins are a family of naturally oc-
curring fatty acids that participate in the in-
flammatory process' 4 and exhibit hormone-
like effects.5,6 When prostaglandins are in-
jected intradermally, they produce local in-
flammatory effects such as increased vascular
permeability with edema and vasodilatation
with erythema.7,8 They have been identified
in inflammatory exudates9-11 and their bio-
synthesis is inhibited by nonsteroidal anti-in-
flammatory drugs.12-15
The prostaglandins PGE,, PGE2, and to a
lesser extent PGF2a stimulate resorption of
cultured fetal rat bones.16'17 In these systems
E-type prostaglandins are more potent than
is parathyroid hormone in producing bone
resorption, although osteolytic action occurs
at a slower rate. The action of the E-type
prostaglandins and parathyroid hormone is
accompanied by elevation of bone cyclic
3'-5' adenosine monophosphate.18
When they are injected systematically,
prostaglandins are rapidly metabolized19'20
by 15 dehydrogenation and by reduction of
the 13-14 double bond (Fig 1). The biologic
activity of the metabolic products is reduced
substantially.
Because of the rapid inactivation and low
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blood levels, and since large doses of prosta-
glandins that are injected intraperitoneally
fail to produce elevated blood calcium in
parathyroidectomized rats,16 prostaglandins
do not normally participate as blood-borne
humoral elements that regulate calcium me-
tabolism like the parathyroid hormone. How-
ever, this does not preclude a role in the
production of localized osteolytic lesions.
Since most forms of periodontal disease are
associated with inflammation and extensive
loss, the participation of prostaglandins in
this disease process should be considered.
The purpose of this paper is to describe
morphologic alteration that is produced by
prostaglandin injection over bone surfaces of
the adult rat and to discuss the possible rele-
vance of this process to periodontal disease.
Materials and Methods
The effect of prostaglandins on bone mor-
phology was investigated in 250 gm adult
male Sprague-Dawley rats. Solutions or sus-
pensions that contained prostaglandins were
injected over the calvaria.
Injections were made with a 0.25-ml tuber-
culin syringe by penetration of the skin with
a 26-gauge, half-inch needle at a point mid-
way between the eyes; the needle passed
parallel to the skull in the direction of the
calvarium. The solution was deposited over
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FIG 1.-Chemical structure of prostaglandin E1.
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the periosteal surface of the frontal and
parietal bones-1.5 cm posterior to the junc-
tion of the zygomatic arch and the maxilla.
The rats were anesthetized with light ether.
Glycerol, saline, peanut oil, and agar were
tested as vehicles. Solutions for injection
were made from a concentrated stock PGE1
solution (10 ytg/ul) that was prepared by
adding 1 ml ethanol to 10 mg PGE1.a Gly-
cerol, saline, and peanut oil solutions were
made by pipetting 50 ul of stock into 500 pJ
of vehicle. Fifty-five microliters of this solu-
tion containing 50 [tg PGE1 was injected.
Control rats were injected similarly with a
solution containing 50 of vehicle and 5
[d of ethanol. Early prostaglandin effects
were studied in six animals that were killed
in pairs after one, three, and five daily in-
jections of PGE1 in glycerol.
The use of agar as a vehicle was tested in
four rats. A 1% agar solution was made by
heating it to 100 C. The agar was cooled to
60 C and PGE1 in ethanol was added. The
ethanol evaporated rapidly leaving a sus-
pension of PGE1 crystals in agar. Fifty mi-
croliters of this suspension containing 100
ytg PGE1 was injected with a warmed 0.25-ml
tuberculin syringe and a 26-gauge needle over
the calvaria of two rats. Two control rats
were injected similarly with agar alone.
Injection parameters for calvaria experi-
ments are listed in the Table. Rats were in-
jected daily and they were killed with an
overdose of pentobarbital sodium. The cal-
varia from half of the rats were prepared for
histological observation by fixation in a 10%
w/v formaldehyde solution and they were de-
calcified in a 6 N formic acid solution with
0.3 sodium citrate for seven days. Decalcified
tissues were embedded in paraffin, sectioned
at 5 micrometers (um), stained with hema-
toxylin and eosin, and photographed. Early
effects were investigated histologically only.
The remainder of the skulls were defleshed
by boiling to observe macroscopic changes in
the superficial bone morphology.
Prostaglandin effects on alveolar bone were
also investigated. A concentrated suspension
of PGE1 in glycerol was prepared for injec-
tion in the alveolar region of two rats. The
suspension was injected with a 10-t1 syringes
that is capable of handling high viscosity
liquids. Five microliters containing 50 ,ug
a Upjohn Corp., Kalamazoo, Mich.
b Difco Laboratories, Detroit, Mich.
e Hamilton No. 701, Reno, Nev.
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50 7 10 50 ,pl glycerol and
0 7 10 5.ul ethanol
50 7 2 50 1.l saline and
0 7 2 5,ul ethanol
50 7 2 50 ,u1 peanut oil and














50 ,ul glycerol and
5 ,1 ethanol
* Rats were killed one day after their last injection;
animals that received agar injections were killed seven
days after the single injection.
PGE1 was injected daily for seven days over
the alveolar bone on the distal surface of
the mandibular incisors. On the eighth day,
the mandible was removed for histological
processing. Control injections of glycerol
were made on the contralateral side. Tissues
were prepared for histology as were the
calvaria.
Results
After seven days of repeated injection of
50 jug PGE1 in glycerol, gross inspection of
the injection site showed a localized area of
highly vascular connective tissue. When the
skull was boiled to remove soft tissue, a
roughened area was observed on the cal-
varial surface beneath the site of prosta-
glandin injection in all the experimental
rats; (Fig 2, top). This was not seen in rats
that were injected with vehicle alone (Fig 2,
bottom) .
Low power observation of decalcified sec-
tions of prostaglandin-treated calvaria shows
extensive loss of bone matrix and fibrous re-
placement (Fig 3, top). Calvaria from ani-
mals that were injected with the vehicle
alone exhibited a subcutaneous fibrous reac-
tion and some hemorrhage at the injection
site; however no erosion of the bone sur-
face was present (Fig 3, bottom).
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FIG 2.-Macroscopic appearance of the calvarium of an adult rat. Top,
after repeated injection of PGE1; bottom, after repeated injection of vehicle.
Microscopic examination of uninjected rat
calvaria showed a dense bone matrix that
was covered by a thin periosteal layer and
loose subcutaneous connective tissue (Fig 4).
The bone matrix had a regular lamellar
structure that ran parallel to the bone sur-
face. The matrix contained occasional small
osteocytes at irregular intervals. The perio-
steal layer showed thin cells with flattened
nuclei. The subcutaneous connective tissue
contained few cellular or formed elements.
Repeated injections of glycerol produced a
fibrous reaction in the connective tissue, lbut
no effect on the bone matrix was seen
(Fig 5).
An altered morphology of the periosteal
cells was observed after prostaglandin injec-
tion. Cells of the periosteal layer seemed
enlarged one day after a single injection of
50 itg PGE1 (Fig 6). Formerly flat nuclei
seemed rounded and hyperchromatic. Areas
of the bone matrix along the periosteal str-
face were irregular. There was an increased
cellularity in the subcutaneous connective
tissue layer.
During the course of repeated daily prosta-
glandin injections, a higher degree of bone
matrix irregularity appeared. After three
days of repeated injection, the laminar pat-
tern was partially interrupted and blood ves-
sels were more numerous in the subcutaneous
connective tissue (Fig 7) In addition to the
erosive pattern that is usually seen, areas
were found where new growth occurred as
irregular outcroppings from the original
laminar surface (Fig 8). These growths oc-
curred most often toward the periphery of
the injection site.
Seven days after a single injection of 100
ftg PGE1 in agar, a bone lesion similar to the





FIG 3.-Low power cross section of decalcified calvaria from prostaglandin-injected (top) and
glycerol-injected (bottom) rats.
lesion seen after seven days of repeated
PGE1 injection was produced (Fig 9). In
this instance the injection artifact was min-
imal in that no area that was injected with
agar alone differed substantially from the
calvaria of uninjected rats. The most promi-
nent effect was an extensive loss of bone ma-
trix, which had been replaced by cellular
connective tissue. Many blood vessels ap-
peared in the cellular stroma surrounding
isolated bone spicules. The resorbing sur-
faces of the bone matrix (Fig 10) were lined
predominantly with uninuclear cells with
dark-staining nuclei. These cells were found
often in lacunae. Osteocytes seemed some-
what enlarged and prominent within the re-
maining bone matrix. The lamellar struc-
ture of several areas was disrupted; in some
cases it departed frim the original parallel
structure. Multinucleated cells were infre-
r i
FIG 4.-Calvarial surface of uninjected rat
(calibration - 50 pxm)
FIG 5.-Calvarial surface after seven days of
repeated injection of glycerol vehicle (calibra-
tion = 50 gxm).





FIG 6.-Altered periosteal morphology along
calvarial surface after a single injection of PGE,
(calibration = 50 /.Lm) .
FIG 9.-Surface of rat calvarium injected with
100 Ag PGE1 in agar after seven days (calibra-
tion = 200 Am)
FIG 7.-Disrupted lamellar contour on cal-
varial surface after three daily injections of PGE,
(calibration - 50 jum) .
FIG 8.-Irregular bone matrix outcroppings ob-
served in some areas on calvarial surface after
five daily injections of PGE1 (calibration = 50
Um) .
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FIG 10.-Enlargement of boxed area in Figure
9. Extensive resorption of bone matrix results
in formation of isolatedl bone spicules (calibra-







PROSTA GLANDIN-INDUCED RESORPTION 675
Flr 11.-Effect of PGE1 injected over rat alveolar bone (right arrow) as compared with
vehicle injection site (left arrow)
quently observed. No signs of leukocyte in-
filtration or exudate formation were ap-
parent.
Repeated injection of PGE1 containing
suspension over rat alveolar bone produced
a resorptive pattern similar to that which
was seen in the calvaria. A low magnifica-
tion view from a section that was taken
parallel to the mandible through the in-
cisors at the injection site showed discon-
tinuity in the alveolar plate on the side of
the PGE1 injection. Higher magnification
views (Fig 12) showed that the bone at the
PGE1 injection site seemed to be partially
resorbed and replaced by cellular connective
tissue. This discontinuity was not seen on
the side that was injected with glycerol
(Fig 11).
Saline and peanut oil were inferior to glyc-
erol as vehicles. Prostaglandin solutions in
saline were not effective in producing a bone
lesion. Prostaglandin solutions in peanut oil
produced a bone lesion; however, animals
that were injected with the vehicle alone
showed a similar but smaller lesion.
Discussion
Prostaglandin administration did not
mimic the periodontal disease process but
there are at least three aspects in which
..
FIG 12.-Top, higher power view of alveolar
bone discontinuity on side of PGE1 injection
(calibration =- 50 prm). Bottomt enlargement of
boxed area shows cellular detail of bone spicules
apparently undergoing resorption at PGE1 injec-
tion site (calibration = 50 pm)
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prostaglandin-induced bone resorption re-
sembled that of the disease.21 It involved the
action of live cells on viable bone; resorbing
surfaces were sculptured with covelike la-
cunae; and there was a strong suggestion of
vascular component to the resorption process.
Prostaglandin-induced bone resorption dif-
fered from the histological appearance of
periodontal disease in its absence of inflam-
matory cells. However, there is considerable
evidence that oral bacteria stimulate the
formation of chemotactic factors.22 This
could account for the inflammatory cell in-
filtration that is characteristic of periodontal
disease. Leukocytes may be especially im-
portant in this connection because there is
evidence that they release prostaglandins23
and another osteolytic principle.24
Prostaglandins are slightly chemotactic.3
The absence of a significant infiltration of
inflammatory cells at the site of prosta-
glandin injection indicated a negligible
chemotactic effect in the rat subcutaneous
connective tissue. Furthermore, this finding
indicated that bacterial inflammation was
not introduced inadvertently as a result of
the injection procedure.
Increased vascularity associated with bone
resorption was observed commonly. Al-
though the vasodilator action of prosta-
glandins is well known,5 stimulation of new
blood vessel formation with chronic admin-
istration has not been studied. Under the
conditions of these experiments, it cannot be
ruled out that increased vascularity could
have been mediated indirectly by products
of the resorptive process.
The concentration of PGE1 that was used
in this study (3 mM) was greater than the
levels that occur in tissue. Failure of saline
as a vehicle suggests that washout is rela-
tively rapid; this is expected of a vasodilator
substance.
Conclusions
A subcutaneous injection of prostaglandin
E1 over a bone surface stimulated rapid
resorption of bone matrix in the adult rat.
The earliest morphologic alterations observed
were associated with the fibroblasts of the
periosteal layer. As the resorptive process
continued, areas of resorbed bone matrix de-
veloped. Cellular connective tissue contain-
ing newly formed vascular elements replaced
the former bone matrix. Some areas showed
signs of irregular formation of new bone. In-
flammatory cells were absent and multinu-
cleated osteoclasts were uncommon.
The rapidity and extent to which bone re-
sorption was produced by prostaglandin in-
jection suggests that a local synthesis of
lesser amounts over a longer period of time
could account for the bone loss in localized
bone-wasting diseases. The recent elucida-
tion of prostaglandins as inflammatory med-
iators offers a plausible hypothesis for their
genesis in periodontal disease.
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